Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 27, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 13, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 9, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 18, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 15, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 11, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 9, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 5, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 19, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 14, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-116

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information